Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Indomethacin: A Precision Tool for Adipocyte and Membrane Re
2026-06-15
Explore how Indomethacin, a nonsteroidal anti-inflammatory drug, enables advanced inflammation research and lipid metabolism studies through its unique Cox-1 selectivity and PPARγ agonism. This article reveals new mechanistic insights and practical assay guidance for researchers.
-
C-Terminal Mutations in VZV gE Enhance mRNA Vaccine Efficacy
2026-06-15
This study evaluates how carboxyl-terminal mutations in varicella-zoster virus glycoprotein E (gE) affect mRNA vaccine performance. Findings indicate that specific C-terminal modifications improve both humoral and cellular immune responses, suggesting enhanced vaccine candidates for varicella and zoster.
-
LGK-974 (PORCN Inhibitor): Unraveling Wnt Pathway Dynamics i
2026-06-14
Explore how LGK-974, a potent PORCN inhibitor, enables precise dissection of Wnt signaling in both developmental biology and Wnt-driven cancer research. This in-depth analysis uniquely bridges evolutionary insights with advanced laboratory applications.
-
DFCP1 Modulates Starvation-Induced ATGL Activity in Lipid Dr
2026-06-13
A recent study reveals that DFCP1 acts as a nutrient-sensitive regulator of lipid droplet lipolysis by controlling ATGL localization and activity during starvation. This mechanistic insight advances our understanding of lipid storage and mobilization, with implications for research into metabolic stress and protein stability assays.
-
PKH26 Red Fluorescent Cell Linker Kit: Technical Use and QC
2026-06-12
The PKH26 Red Fluorescent Cell Linker Kit provides stable, minimally toxic fluorescent labeling of cell membrane lipid regions for cell tracing and proliferation detection in both in vitro and in vivo research. It is not suitable for intracellular or non-membrane applications and requires strict adherence to protocol parameters for reproducible, reliable results.
-
Phosbind Acrylamide: Precision Phosphate-Binding for SDS-PAG
2026-06-12
Phosbind Acrylamide empowers researchers to dissect phosphorylation states rapidly and antibody-free, streamlining SDS-PAGE–based phosphorylation analysis. Its robust phosphate-binding chemistry enables direct, quantitative visualization of phospho-isoforms, driving advances in circadian signaling and kinase pathway research.
-
Optimizing Cancer Assays with BV6: From IAP Antagonism to Ra
2026-06-11
BV6, a potent IAP antagonist, empowers researchers to reliably induce apoptosis and sensitize cancer cells to chemoradiotherapy. This article dives into advanced workflows, actionable troubleshooting, and protocol optimization, bridging foundational mechanism with practical assay outcomes.
-
EPI-001: Unraveling AR N-Terminal Domain Inhibition in Cance
2026-06-11
Explore the advanced applications of EPI-001, a potent androgen receptor N-terminal domain inhibitor, in prostate and triple-negative breast cancer research. This article provides a deep dive into its molecular mechanism, protocol optimization, and translational impact, offering uniquely actionable insights for AR-driven disease models.
-
Applied Workflows for Resiniferatoxin (RTX) in TRPV1 Researc
2026-06-10
Resiniferatoxin (RTX) enables ultra-selective, long-lasting TRPV1 desensitization, offering unmatched control in pain and neurogenic inflammation models. This guide translates recent mechanistic insights and reference-backed troubleshooting into actionable protocols for reproducible, high-impact research.
-
Triacetin Digestion and Hepatic Metabolic Regulation in Rats
2026-06-10
This study elucidates the complete digestive fate of triacetin, a short-chain triglyceride, in rats. The findings reveal that triacetin is fully degraded in the upper gastrointestinal tract and its metabolites directly modulate hepatic energy metabolism, offering new insights for metabolic research.
-
Non-Canonical Dlat-Trpv3 Pathway Drives Adipose Thermogenesi
2026-06-09
This study demonstrates that hyperforin activates adipose thermogenesis via the Dlat-Trpv3-Ca2+-AMPK axis, offering a distinct alternative to β3-adrenergic stimulation for obesity control. The findings reveal a mechanistic avenue with minimal cardiotoxicity and suggest new strategies for metabolic intervention.
-
Difloxacin HCl: Beyond Antimicrobial Testing to Cell Cycle I
2026-06-09
Explore the dual role of Difloxacin HCl as a quinolone antimicrobial antibiotic and a tool for probing cell cycle checkpoint regulation. This article uniquely bridges antimicrobial susceptibility testing with advanced oncology research applications.
-
EPI-001: Androgen Receptor N-Terminal Domain Inhibitor Workf
2026-06-08
EPI-001, a potent androgen receptor N-terminal domain inhibitor, uniquely targets both full-length AR and its splice variants, overcoming resistance mechanisms in prostate and triple-negative breast cancer models. This article delivers actionable workflows, protocol refinements, and troubleshooting strategies for maximizing the compound’s translational impact in AR-driven oncology research.
-
10074-G5: Advanced Insights into c-Myc Inhibition and Cancer
2026-06-08
Explore the molecular intricacies of 10074-G5, a leading c-Myc inhibitor, and its role in disrupting oncogenic signaling for cancer research. This article offers a uniquely in-depth analysis of c-Myc/Max dimerization inhibition and practical guidance for translational assay design.
-
Trichostatin A (TSA): Precision Epigenetic Modulation in Can
2026-06-07
Trichostatin A (TSA) empowers researchers to dissect epigenetic regulation in cancer and bone biology with robust, reproducible workflows. Recent breakthroughs reveal TSA’s unique role in enhancing titanium implant integration via oxidative stress modulation, positioning it as a versatile tool for both oncology and regenerative medicine applications.